News

Glycemic index doesn’t affect insulin sensitivity, lipid levels

View on the News

Overall dietary pattern most important

The unexpected findings by Sacks et al. suggest that glycemic index is less important than previously thought, especially in the context of an overall healthy diet, as tested in this study.

These results should direct attention back to the importance of maintaining an overall heart-healthy lifestyle rather than focusing on a narrow concept such as the glycemic index of individual foods. It isn’t a matter of good foods and bad foods, but the overall dietary pattern that is important.

Dr. Robert H. Eckel of the University of Colorado, Aurora, made these remarks in an editorial accompanying Dr. Sacks’s report (JAMA 2014;312:2508-9). He reported having no financial disclosures.


 

References

A healthy diet that was modified to have a low glycemic index did not improve insulin sensitivity, lipid levels, or blood pressure in overweight and obese adults, compared with one with a high glycemic index, according to a report published online Dec. 16 in JAMA.

This unexpected finding indicates that, against a background diet that is already healthy, “using glycemic index to select specific foods may not improve cardiovascular risk factors or insulin resistance,” said Dr. Frank M. Sacks of the department of nutrition, Harvard School of Public Health, Boston, and his associates.

The investigators performed a randomized, crossover feeding study in which 163 people aged at least 30 years were randomly assigned to one of four study diets for 5 weeks, then switched to a different diet for a further 5 weeks, after a 2-week washout period.

Dr. Frank M. Sacks

Dr. Frank M. Sacks

“We studied diets that had a large contrast in glycemic index, while at the same time we controlled intake of total carbohydrates and other key nutrients such as fatty acids, potassium, and sodium and maintained body weight. The background diets in which we manipulated glycemic index were healthful dietary patterns established in the Dietary Approaches to Stop Hypertension (DASH) and Optimal Macronutrient Intake to Prevent Heart Disease (OmniHeart) studies that are being recommended in dietary guidelines to prevent CVD,” they noted. About half of the study population were female and half were black, and there were high prevalences of obesity (56%), hypertension (26%), high cholesterol (68%), and impaired fasting glucose (30%). All meals, snacks, and beverages were provided on site. Adherence, which was closely monitored, was high: All study foods and no nonstudy foods were consumed on 96% of person-days on each diet.

Contrary to expectations, the two low-glycemic-index diets failed to improve insulin sensitivity, cholesterol levels, or blood pressure when compared with the two high-glycemic-index diets. “Composing a DASH-type diet with low-glycemic-index foods ... does not improve CVD risk factors and may in fact reduce insulin sensitivity and increase LDL cholesterol,” Dr. Sacks and his associates wrote (JAMA 2014 Dec. 16 [doi:10.1001/jama.2014.16658]).

They noted that these findings are especially important given that some nutrition policies advocate replacing high-glycemic-index with low-glycemic-index foods. Even though some experts go so far as to promote that all foods be labeled with their glycemic-index values, “the benefits of glycemic index are uncertain, especially with persons are already consuming a healthful diet rich in whole grains, vegetables, and fruits.”

The investigators emphasized that none of the study participants had type 2 diabetes, so these findings do not apply to patients with that disease.

Recommended Reading

On-target glycemic control does not lessen excess mortality
MDedge Endocrinology
ZS-9 promotes normokalemia in patients with diabetes and CKD
MDedge Endocrinology
Simple risk score predicts dementia risk in type 2 diabetes
MDedge Endocrinology
Liraglutide lowers HbA1c in diabetic CKD patients
MDedge Endocrinology
Few newly diagnosed diabetics trained in self-management
MDedge Endocrinology
Obesity can cut 19 years of health, 8 years of life
MDedge Endocrinology
Vitamin D landscape marked by lack of consensus
MDedge Endocrinology
Implications of cholesterol guidelines for cardiology practices
MDedge Endocrinology
Kidney function declines faster with high sleep apnea risk
MDedge Endocrinology
Anti-TGF-beta 1 therapy for diabetic nephropathy disappoints
MDedge Endocrinology